Puthiyakunnon S et al.2014. Strongyloidiasis—an insight into its global prevalence and management. PLoS Negl Trop Dis 8: e3018.
Schär F et al.2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: e2288.
Keiser PB, Nutman TB , 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208–217.
Ahmadpour E, Ghanizadegan MA, Razavi A, Kangari M, Seyfi R, Shahdust M , 2019. Strongyloides stercoralis infection in human immunodeficiency virus‐infected patients and related risk factors: a systematic review and meta‐analysis. Transbound Emerg Dis 66: 2233–2243.
Buonfrate D et al.2013. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13: 78.
Mukaigawara M, Narita M, Shiiki S, Takayama Y, Takakura S, Kishaba T , 2020. Clinical characteristics of disseminated strongyloidiasis, Japan, 1975–2017. Emerg Infect Dis 26: 401–408.
Ersöz Ş, Turgutalp H, Akdoğan R, Çobanoğlu Ü, Saygın İ, Mungan S, Özgür O , 2010. Gastric strongyloidiasis in a diabetic patient. Turk J Pathol 26: 71–73.
Lam CS, Tong MK, Chan KM, Siu YP, 2006. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis 25: 14–18.
Aramendia AA et al.2020. Epidemiology of intestinal helminthiases in a rural community of Ethiopia: is it time to expand control programs to include Strongyloides stercoralis and the entire community? PLoS Negl Trop Dis 14: e0008315.
Lessnau KD, Can S, Talavera W , 1993. Disseminated Strongyloides stercoralis in human immunodefciency virus-infected patients. Treatment failure and a review of the literature. Chest 104: 119–122.
Jaka H et al.2013. Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report. Trop Doct 43: 46–48.
Romero-Cabello R, Villagroy Gómez J, Hernández González M, Romero Feregrino R , 2012. Hyperinfection with Strongyloides stercoralis. BMJ Case Rep 30: bcr2012006819.
Meine GC, Dietz J, Rocha M, Mattos T, de Souza AR, Conteletti FR , 2004. Atypical gastric presentation of strongyloidiasis in HIV-infected patient-case report. Dig Liver Dis 36: 760–762.
Malnick S, Somin M, Beilinson N, Basevitch A, Bregman G, Zimhony O , 2009. Strongyloides hyperinfection in Ethiopian immigrants in Israel. Isr Med Assoc J 11: 660–663.
Thompson BF, Fry LC, Wells CD , 2004. Spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc 59: 906–911.
Mohamed R, Hamodat MM, Al-Abbadi MA , 2017. Gastric strongyloidiasis: report of 2 cases and brief review of the literature. Lab Med 48: 93–96.
Sebastian A, Muttath R, Madhavan I, Thomas V , 2014. A case of Strongyloides hyperinfection syndrome. Trop J Med Res 17: 140–142.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 6026 | 389 | 11 |
Full Text Views | 132 | 86 | 30 |
PDF Downloads | 76 | 28 | 0 |
Disseminated Strongloides stercoralis is a common phenomenon among patients with immunosuppression. In this report, we present a case of disseminated Strongloides stercoralis presenting as a gastric mass in a 42-year-old male patient with a known history of HIV-1 infection and type 2 diabetes mellitus (T2DM). The patient presented with symptoms and signs suggestive of acute on chronic erosive gastritis, which included persistent vomiting. Endoscopic examination revealed a gastric mass with no signs of malignancy or dysplasia. There was noted to be chronic inflammation along with morphologic features consistent with the larvae and eggs of Strongloides nematodes in a biopsied gastric mass tissue and duodenum. The disease subsequently resulted in death despite the administration of ivermectin.
Authors’ addresses: Kassa Tameru and Mohammed Shikur, Internal Medicine, Amin General Hospital, Addis Ababa, Ethiopia, E-mails: ktameru@yahoo.com and mosmigemusa@hotmail.com. Bekure Tsegaye and Wondwossen Ergete, Pathology, Amin General Hospital, Addis Ababa, Ethiopia, E-mails: bekure_tsegaye@yahoo.com and wondwossen_ergete@yahoo.com. Adugna Abera and Geremew Tasew, Bacterial, Fungal and Zoonotic Diseases Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia, E-mails: adugnabe@yahoo.com and getas73@yahoo.com. Dawit Wolday, Medicine, Mekelle University College of Health Sciences, Mekelle, Ethiopia, E-mail: dawwol@gmail.com.
Puthiyakunnon S et al.2014. Strongyloidiasis—an insight into its global prevalence and management. PLoS Negl Trop Dis 8: e3018.
Schär F et al.2013. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 7: e2288.
Keiser PB, Nutman TB , 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208–217.
Ahmadpour E, Ghanizadegan MA, Razavi A, Kangari M, Seyfi R, Shahdust M , 2019. Strongyloides stercoralis infection in human immunodeficiency virus‐infected patients and related risk factors: a systematic review and meta‐analysis. Transbound Emerg Dis 66: 2233–2243.
Buonfrate D et al.2013. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 13: 78.
Mukaigawara M, Narita M, Shiiki S, Takayama Y, Takakura S, Kishaba T , 2020. Clinical characteristics of disseminated strongyloidiasis, Japan, 1975–2017. Emerg Infect Dis 26: 401–408.
Ersöz Ş, Turgutalp H, Akdoğan R, Çobanoğlu Ü, Saygın İ, Mungan S, Özgür O , 2010. Gastric strongyloidiasis in a diabetic patient. Turk J Pathol 26: 71–73.
Lam CS, Tong MK, Chan KM, Siu YP, 2006. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis 25: 14–18.
Aramendia AA et al.2020. Epidemiology of intestinal helminthiases in a rural community of Ethiopia: is it time to expand control programs to include Strongyloides stercoralis and the entire community? PLoS Negl Trop Dis 14: e0008315.
Lessnau KD, Can S, Talavera W , 1993. Disseminated Strongyloides stercoralis in human immunodefciency virus-infected patients. Treatment failure and a review of the literature. Chest 104: 119–122.
Jaka H et al.2013. Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report. Trop Doct 43: 46–48.
Romero-Cabello R, Villagroy Gómez J, Hernández González M, Romero Feregrino R , 2012. Hyperinfection with Strongyloides stercoralis. BMJ Case Rep 30: bcr2012006819.
Meine GC, Dietz J, Rocha M, Mattos T, de Souza AR, Conteletti FR , 2004. Atypical gastric presentation of strongyloidiasis in HIV-infected patient-case report. Dig Liver Dis 36: 760–762.
Malnick S, Somin M, Beilinson N, Basevitch A, Bregman G, Zimhony O , 2009. Strongyloides hyperinfection in Ethiopian immigrants in Israel. Isr Med Assoc J 11: 660–663.
Thompson BF, Fry LC, Wells CD , 2004. Spectrum of GI strongyloidiasis: an endoscopic-pathologic study. Gastrointest Endosc 59: 906–911.
Mohamed R, Hamodat MM, Al-Abbadi MA , 2017. Gastric strongyloidiasis: report of 2 cases and brief review of the literature. Lab Med 48: 93–96.
Sebastian A, Muttath R, Madhavan I, Thomas V , 2014. A case of Strongyloides hyperinfection syndrome. Trop J Med Res 17: 140–142.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 6026 | 389 | 11 |
Full Text Views | 132 | 86 | 30 |
PDF Downloads | 76 | 28 | 0 |